Education
About Us
Working with TipRanks
Follow Us
EXACT Therapeutics AS (DE:56F)
:56F
56F Stock Chart & Stats
€0.13
>-€0.01(-2.36%)
At close: 4:00 PM EST
€0.13
>-€0.01(-2.36%)
Day’s Range― - ―
52-Week Range€0.09 - €0.51
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€8.08M
Enterprise Value€108.66M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.49
Next Earnings
Apr 17, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.07
Shares Outstanding63,263,348
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
EXACT Therapeutics AS News
56F FAQ
What was EXACT Therapeutics AS’s price range in the past 12 months?
EXACT Therapeutics AS lowest stock price was €0.09 and its highest was €0.51 in the past 12 months.
What is EXACT Therapeutics AS’s market cap?
EXACT Therapeutics AS’s market cap is €8.08M.
When is EXACT Therapeutics AS’s upcoming earnings report date?
EXACT Therapeutics AS’s upcoming earnings report date is Apr 17, 2026 which is in 161 days.
How were EXACT Therapeutics AS’s earnings last quarter?
EXACT Therapeutics AS released its earnings results on Sep 18, 2025. The company reported -€0.067 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.067.
Is EXACT Therapeutics AS overvalued?
According to Wall Street analysts EXACT Therapeutics AS’s price is currently Overvalued.
Does EXACT Therapeutics AS pay dividends?
EXACT Therapeutics AS does not currently pay dividends.
What is EXACT Therapeutics AS’s EPS estimate?
EXACT Therapeutics AS’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does EXACT Therapeutics AS have?
EXACT Therapeutics AS has 63,263,348 shares outstanding.
What happened to EXACT Therapeutics AS’s price movement after its last earnings report?
EXACT Therapeutics AS reported an EPS of -€0.067 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -6.25%.
Which hedge fund is a major shareholder of EXACT Therapeutics AS?
Currently, no hedge funds are holding shares in DE:56F
Company Description
EXACT Therapeutics AS
Exact Therapeutics AS is a clinical-stage biotechnology company. It is developing a technology platform for therapeutic enhancement - Acoustic Cluster Therapy (ACT). ACT sonoporation is an approach to ultrasound-mediated, targeted drug enhancement that will amplify the clinical utility of therapeutic agents across a multitude of indications including within oncology (chemotherapy, immunotherapy), infectious diseases, and neurological conditions.